Posted innews Ophthalmology
Advancing Vision: Optogenetic Therapy Offers Hope for Retinitis Pigmentosa Patients
An open-label trial demonstrates the safety and potential efficacy of ChrimsonR-based optogenetic therapy combined with specialized goggles to enhance light sensitivity in patients with advanced retinitis pigmentosa, offering promising avenues for restoring visual function.